90.92
Spdr Biotech Etf stock is traded at $90.92, with a volume of 9.81M.
It is up +1.11% in the last 24 hours and up +4.83% over the past month.
See More
Previous Close:
$89.92
Open:
$90.29
24h Volume:
9.81M
Relative Volume:
0.99
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.26%
1M Performance:
+4.83%
6M Performance:
-0.85%
1Y Performance:
-9.21%
Spdr Biotech Etf Stock (XBI) Company Profile
Name
Spdr Biotech Etf
Sector
Industry
Phone
-
Address
-
Compare XBI with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
XBI
Spdr Biotech Etf
|
90.92 | 0 | 0 | 0 | 0 | 0.00 |
![]()
VTI
Vanguard Total Stock Market Etf
|
318.18 | 417.53B | 0 | 0 | 0 | 0.00 |
![]()
SPY
Spdr S P 500 Etf Trust
|
645.30 | 372.57B | 0 | 0 | 0 | 0.00 |
![]()
IVV
Ishares Core S P 500 Etf
|
648.51 | 253.41B | 0 | 0 | 0 | 0.00 |
![]()
VB
Vanguard Small Cap Etf
|
252.41 | 160.59B | 0 | 0 | 0 | 0.00 |
![]()
QQQ
Invesco Qqq Trust Series 1
|
571.97 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Biotech Etf Stock (XBI) Latest News
Precision Trading with Spdr Biotech Etf (XBI) Risk Zones - news.stocktradersdaily.com
(XBI) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Trading Systems Reacting to (XBI) Volatility - news.stocktradersdaily.com
Inside XBI: What The SPDR S&P Biotech ETF Offers Investors (NYSEARCA:XBI) - Seeking Alpha
Technical Reactions to XBI Trends in Macro Strategies - news.stocktradersdaily.com
How Spdr Biotech Etf (XBI) Affects Rotational Strategy Timing - news.stocktradersdaily.com
(XBI) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Healthcare Sector's Attractive Valuations and Structural Resilience in a Post-Pandemic Recovery - AInvest
Assessing the Political and Policy Risks in the 2028 U.S. Presidential Race and Their Impact on Health and Biotech Sectors - AInvest
Health and Human Services Secretary Robert F. Kennedy Jr. Disavows 2028 Presidential Run, Pledges Loyalty to Trump. - AInvest
Stock Market: This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine - Investor's Business Daily
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - MSN
The Vaccine Hesitancy Dilemma: How Political and Social Hostility Threaten Biotech and Pharma Equities - AInvest
7 Best Biotech ETFs to Buy Now - US News Money
ETF Talk: Create the Future with This ETF - Stock Investor
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Finance
US Bancorp DE Reduces Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF - Nasdaq
Atria Wealth Solutions Inc. Sells 2,438 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
6 of the Best AI ETFs to Buy for 2025 - US News Money
Prasad’s FDA Return Adds to Leadership Turmoil at U.S. Health Agencies - Barron's
FDA Leadership Shifts and Their Impact on Biotech Valuations: Navigating Regulatory Risk in the Post-Vinay Prasad Era - AInvest
Regulatory Leadership Volatility: How FDA Reinstatements Reshape Biotech Investment Landscapes - AInvest
The AI-Driven Medtech Revolution: Why Heartflow's IPO Signals a Strategic Buy in a Shifting Market - AInvest
Zurcher Kantonalbank Zurich Cantonalbank Sells 19,021 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
QQQ Tops Daily ETF Inflows - ETF.com
Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains. - MSN
Hutchmed Plummets 9.7% on Earnings Volatility: Is This a Buying Opportunity or a Warning Signal? - AInvest
Is It Time to Buy Biotech Stocks? - The Motley Fool
Healthcare Stocks Sent Mixed Signals As Deals And Politics Took Center Stage - Finimize
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Bank of New York Mellon Corp - Defense World
The World’s First AI Genome Editor - Brownstone Research
BBH- A Biotech Fund That's Ripe for a Major Turnaround - Yahoo Finance
(08/04/25) BBH: A Biotech Fund That’s Ripe for a Major Turnaround - moneyshow.com
SPDR S&P Biotech ETF (NYSEARCA:XBI) Sees Large Growth in Short Interest - Defense World
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by LPL Financial LLC - Defense World
N.E.W. Advisory Services LLC Acquires New Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Lyell Wealth Management LP Has $1.18 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
BREAKING: Surprise FDA Exit May Boost Biotech ETF XBI - AInvest
XBI: Surprise Exit Of A Tough Regulator At The FDA (NYSEARCA:XBI) - Seeking Alpha
Letko Brosseau & Associates Inc. Has $3.24 Million Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Cetera Investment Advisers Buys 5,604 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - Yahoo Finance
IFP Advisors Inc Decreases Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
6 Best Health Care Funds and ETFs for 2025 | Investing - Money/ US News
(XBI) Trading Advice - news.stocktradersdaily.com
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by Cerity Partners LLC - Defense World
Cerity Partners LLC Has $1.51 Million Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
Envestnet Asset Management Inc. Sells 16,015 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
M&T Bank Corp Has $446,000 Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) - Defense World
SPDR S&P Biotech ETF (NYSEARCA:XBI) Stake Lowered by Stratos Wealth Partners LTD. - Defense World
Spdr Biotech Etf Stock (XBI) Financials Data
There is no financial data for Spdr Biotech Etf (XBI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):